C O M M U N I C A T I O N S
Table 1. Synthesis of Sialoside Libraries Using tPm0188Ph in a
One-Pot Three-Enzyme System, as Shown in Scheme 1
The tPm0188Ph R2,3SiaT also had relaxed acceptor specificity.
As shown in Table 1, N-acetyllactosamine (entry a), lactose (entries
b and l), and â-lactosides with methyl (entries f, q, t, and u), azido
(entries c and p), azidopropyl (entries d, m, o, and v), or
4-methylumbelliferyl (entries e, r, and s) aglycons were excellent
acceptors. Galactose (entry g) and â-galactosides (entries h, i, j,
and n) were good acceptors. Similar to that reported for the N.
meningitidis R2,3SiaT,3a an R-galactoside (e.g., R-methylgalacto-
side, entry k) was an acceptor for tPm0188Ph. N-Acetylgalac-
tosamine (GalNAc) and its derivatives, such as RGalNAcProN3 and
âGalNAcProN3, however, were not acceptors.
By controlling the pH value of reaction, tPm0188Ph could be
used in synthesizing R2,6-linked sialosides. For example, Neu5AcR2,-
6LacMU was obtained in 5.5% yield using a one-pot two-step
reaction in which CMP-Neu5Ac was synthesized at pH 8.8 in the
first step catalyzed by the sialic acid aldolase and the CMP-Sia
synthetase. After acidification of the reaction to pH 5.5, tPm0188Ph
was added and the trisaccharide was produced in the second step
without isolating the CMP-Neu5Ac intermediate.
The application of the trans-sialidase activity of tPm0188Ph in
the synthesis of sialosides was also tested. In this case, Neu5AcR2,-
3LacMU was obtained in 36% yield from Neu5AcR2,3-lactose and
LacMU.
In conclusion, due to its broad substrate specificity, high
solubility, high expression level, and multifunctionality, the newly
discovered P. multocida SiaT tPm0188Ph is an extremely powerful
tool for synthesizing structurally diverse sialosides to understand
their important biological functions. The unusual multifunctionality
of the enzyme as an R2,3SiaT, an R2,6SiaT, an R2,3-sialidase, and
an R2,3-trans-sialidase also provides solid evidence for the
complexity of bacterial sialylation.
Acknowledgment. This work was supported by Mizutani
Foundation for Glycoscience, New Faculty Research Grant, and
start-up funds from the Regents of the University of California.
Supporting Information Available: Experimental details for
cloning, expression, purification, and characterization of tPm0188Ph,
and details for chemoenzymatic synthesis of sialosides. This material
References
(1) (a) Angata, T.; Varki, A. Chem. ReV. 2002, 102, 439-469. (b) Schauer,
R. Glycoconjugate J. 2000, 17, 485-499.
(2) (a) Izumi, M.; Shen, G. J.; Wacowich-Sgarbi, S.; Nakatani, T.; Plettenburg,
O.; Wong, C.-H. J. Am. Chem. Soc. 2001, 123, 10909-10918. (b) Boons,
G. J.; Demchenko, A. V. Chem. ReV. 2000, 100, 4539-4566.
(3) (a) Gilbert, M.; Cunningham, A. M.; Watson, D. C.; Martin, A.; Richards,
J. C.; Wakarchuk, W. W. Eur. J. Biochem. 1997, 249, 187-194. (b)
Yamamoto, T.; Nakashizuka, M.; Kodama, H.; Kajihara, Y.; Terada, I. J.
Biochem. 1996, 120, 104-110. (c) Kajihara, Y.; Yamamoto, T.; Nagae,
H.; Nakashizuka, M.; Sakakibara, T.; Terada, I. J. Org. Chem. 1996, 61,
8632-8635. (d) Blixt, O.; Vasiliu, D.; Allin, K.; Jacobsen, N.; Warnock,
D.; Razi, N.; Paulson, J. C.; Bernatchez, S.; Gilbert, M.; Wakarchuk, W.
Carbohydr. Res. 2005, 340, 1963-1972. (e) Gilbert, M.; Bayer, R.;
Cunningham, A. M.; DeFrees, S.; Gao, Y.; Watson, D. C.; Young, N.
M.; Wakarchuk, W. W. Nat. Biotechnol. 1998, 16, 769-772.
(4) (a) Koeller, K. M.; Wong, C.-H. Nature 2001, 409, 232-240. (b) Blixt,
O.; Allin, K.; Pereira, L.; Datta, A.; Paulson, J. C. J. Am. Chem. Soc.
2002, 124, 5739-5746. (c) Blixt, O.; Paulson, J. C. AdV. Synth. Catal.
2003, 345, 687-690.
a All reactions were carried out in preparative (50-150 mg) scales.
accepted CMP activated Neu5Ac, KDN (deaminoneuraminic acid),
and Neu5Gc (N-glycolylneuraminic acid) obtained in situ from their
corresponding precursors ManNAc (N-acetylmannosamine) 1, man-
nose 2, and ManNGc (N-glycolylmannosamine) 3, respectively.5a
In comparison, CMP-Neu5Gc and CMP-KDN were poor sub-
strates for N. gonorrheae R2,3SiaT,2a and the N. meningitidis R2,-
3SiaT could not use CMP-KDN as a donor.4c In addition, CMP-
Sia derivatives with modifications at C-5 or C-9 in Neu5Ac or KDN
obtained in situ from C-2 or C-6-modified ManNAc or mannose
(4-8) were also acceptable by tPm0188Ph. For example, azide or
alkyne groups introduced chemically onto ManNAc or mannose
(4-7) were efficiently transferred to sialoside products, providing
convenient chemical handles for further modifications via Staudinger
ligation7 or Click chemistry.8
(5) (a) Yu, H.; Yu, H.; Karpel, R.; Chen, X. Bioorg. Med. Chem. 2004, 12,
6427-6435. (b) Martin, R.; Witte, K. L.; Wong, C.-H. Bioorg. Med. Chem.
1998, 6, 1283-1292.
(6) Yamamoto, T.; Nakashizuka, M.; Terada, I. J. Biochem. (Tokyo) 1998,
123, 94-100.
(7) (a) Saxon, E.; Bertozzi, C. R. Science 2000, 287, 2007-2010. (b) Lin, F.
L.; Hoyt, H. M.; van Halbeek, H.; Bergman, R. G.; Bertozzi, C. R. J.
Am. Chem. Soc. 2005, 127, 2686-2695.
(8) (a) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew Chem., Int. Ed.
2001, 40, 2004-2021. (b) Fazio, F.; Bryan, M. C.; Blixt, O.; Paulson, J.
C.; Wong, C.-H. J. Am. Chem. Soc. 2002, 124, 14397-14402.
JA0561690
9
J. AM. CHEM. SOC. VOL. 127, NO. 50, 2005 17619